bladder cancer
NIH Awards Early is Good $1.6M for Bladder Cancer Monitoring Test
The firm said that it will use the money to support the clinical validation of its urine-based BCDx multiomic test to detect bladder cancer recurrence.
UK Consortium Launches With Public-Private Funding to ID Immunotherapy Biomarkers
The Francis Crick Institute and the Royal Marsden Foundation Trust are spearheading the MANIFEST project with £21.9 million in government and industry funding.
A. Menarini Gets European Rights to Nucleix Bladder Cancer Test
The CE-marked and FDA-cleared test analyzes disease-specific changes in 15 DNA methylation markers in urine using qPCR.
Informed Genomics, NHS to Study Use of Urine-Based Bladder Cancer Test
Studies planned for this year will be used to evaluate the accuracy of Informed Genomics' Galeas Bladder test and further studies are planned for early 2025.
Bladder Cancer Genomes Reveal Treatment Response-Related Mutations in Driver Gene
Researchers linked ERCC2 mutations to broader somatic mutation and treatment response patterns when they analyzed tumor genome sequences from hundreds of bladder cancers.